Inactive Instrument
DIAL BIORFD Share Price Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 22/11/2023 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 13/06/2024 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 31/12/2020 | |
| Chairman | 70 | 31/12/2020 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 31/12/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.99% | +15.00% | - | - | 705K | |
| +0.56% | -4.71% | -2.45% | +9.18% | 45.63B | |
| +0.66% | -2.34% | +340.62% | +530.14% | 43.96B | |
| +1.49% | -0.78% | +41.90% | +24.75% | 43.73B | |
| +2.11% | -1.24% | +9.09% | +78.25% | 40.23B | |
| +0.34% | -4.03% | +9.34% | +38.90% | 31.86B | |
| +0.53% | -2.08% | - | - | 17.4B | |
| +1.34% | +0.70% | +21.35% | +112.62% | 16.62B | |
| +2.07% | +0.78% | +13.07% | +30.91% | 14.46B | |
| -1.85% | -5.33% | +78.63% | +31.45% | 13.04B | |
| Average | +1.02% | -2.42% | +63.95% | +107.03% | 29.66B | |
| Weighted average by Cap. | +0.95% | -2.82% | +75.86% | +127.94% |
Employees
4
